Skip to main content
Equibles

Soleus Capital Management, L.P.

Position in MBX — MBX Biosciences, Inc.

CIK 1802630 GREENWICH, CT
Back to MBX Full portfolio

Position in MBX

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$28,443,400
+$23,103,325 QoQ
Shares Held
515,279
+188.0% QoQ
Ownership
1.07%
of shares outstanding
% of Portfolio
0.98%
of 13F equity value
Holder Rank
#24
of 172 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in MBX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Soleus Capital Management, L.P. holds $1,753,981,438 across 64 Biotechnology names. MBX ranks #17 (1.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 KRYS
Krystal Biotech, Inc.
 939,254 $349,092,534
2 CELC
Celcuity Inc.
 1,704,318 $178,305,749
3 TGTX
Tg Therapeutics, Inc.
 2,927,895 $160,858,551
4 RIGL
Rigel Pharmaceuticals Inc
 1,843,504 $72,117,876
5 VCEL
Vericel Corp
 1,459,152 $64,917,672
6 PRAX
Praxis Precision Medicines, Inc.
 177,517 $59,430,916
7 GERN
Geron Corp
 42,808,659 $54,795,083
8 ERAS
Erasca, Inc.
 2,700,000 $49,464,000

All Filings in MBX

Export CSV
4 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $28,443,400 515,279
2026-03-31 $5,340,075 178,897
2025-12-31 $12,896,706 408,900
2025-09-30 $4,812,500 275,000